By Finance Pulse in Stock Market —

Sangamo Shares Plummet as Pfizer Ends Partnership

Sangamo Therapeutics stock drops 50% following Pfizer's termination of their co-development agreement. Discover the impact on Sangamo's future prospects.

A dramatic stock chart with a sharp decline, set against a backdrop of Sangamo and Pfizer logos, sym
Sangamo Shares Plummet as Pfizer Ends Partnership

Sangamo Therapeutics shares lost half their value after Pfizer canceled their co-development agreement.

Source